Differential activation of airway eosinophils induces IL-13-mediated allergic Th2 pulmonary responses in mice

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 70, Issue 9, 2015, Pages 1148-1159

  Jacobsen, E A ^a   Doyle, A D ^a   Colbert, D C ^a   Zellner, K R ^a   Protheroe, C A ^a   Lesuer, W E ^a   Lee, N A ^a   Lee, J J ^a  

^a MAYO GRADUATE SCHOOL   (United States)

Author keywords

Asthma; Eosinophil deficient; IL 13; IL 33; T cells

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 13; INTERLEUKIN 33; INTERLEUKIN 4; ALLERGEN; CYTOKINE; OVALBUMIN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL MIGRATION; CONTROLLED STUDY; DENDRITIC CELL; EOSINOPHIL; FEMALE; HISTOPATHOLOGY; IMMUNE RESPONSE; LEUKOCYTE ACTIVATION; LYMPH NODE; MACROPHAGE; MALE; MOUSE; NONHUMAN; OVALBUMIN-INDUCED AIRWAY INFLAMMATION; PRIORITY JOURNAL; TH2 CELL; ANIMAL; CELL CULTURE; DISEASE MODEL; DRUG EFFECTS; GENETICS; HYPERSENSITIVITY; IMMUNOLOGY; LUNG; METABOLISM; PATHOLOGY; PHENOTYPE; TRANSGENIC MOUSE;

ALLERGENS; ANIMALS; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; EOSINOPHILS; FEMALE; HYPERSENSITIVITY; INTERLEUKIN-13; LUNG; MACROPHAGES; MALE; MICE; MICE, TRANSGENIC; OVALBUMIN; PHENOTYPE; TH2 CELLS;

EID: 84940452887     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12655     Document Type: Article

References (45)

1. Holgate ST,. Innate and adaptive immune responses in asthma. Nat Med 2012; 18: 673-683.
2. Gleich GJ, Loegering DA,. Immunobiology of eosinophils. Annu Rev Immunol 1984; 2: 429-459.
3. Lee JJ, Jacobsen EA, McGarry MP, Schleimer RP, Lee NA,. Eosinophils in health and disease: the LIAR hypothesis. Clin Exp Allergy 2010; 40: 563-575.
4. Rosenberg HF, Dyer KD, Foster PS,. Eosinophils: changing perspectives in health and disease. Nat Rev Immunol 2013; 13: 9-22.
5. Fulkerson PC, Fischetti CA, Rothenberg ME,. Eosinophils and CCR3 regulate interleukin-13 transgene-induced pulmonary remodeling. Am J Pathol 2006; 169: 2117-2126.
6. Humbles AA, Lloyd CM, McMillan SJ, Friend DS, Xanthou G, McKenna EE, et al., A critical role for eosinophils in allergic airways remodeling. Science 2004; 305: 1776-1779.
7. Vignola AM, Chanez P, Chiappara G, Merendino A, Pace E, Rizzo A, et al., Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med 1997; 156: 591-599.
8. Takeda K, Shiraishi Y, Ashino S, Han J, Jia Y, Wang M, et al., Eosinophils contribute to the resolution of lung allergic responses following repeated allergen challenge. J Allergy Clin Immunol 2015; 135: 451-460.
9. Isobe Y, Kato T, Arita M,. Emerging roles of eosinophils and eosinophil-derived lipid mediators in the resolution of inflammation. Front Immunol 2012; 3: 270.
10. Jacobsen EA, Zellner KR, Colbert D, Lee NA, Lee JJ,. Eosinophils regulate dendritic cells and Th2 pulmonary immune responses following allergen provocation. J Immunol 2011; 187: 6059-6068.
11. Wang H-B, Ghiran I, Matthaei K, Weller PF,. Airway eosinophils: allergic inflammation recruited professional antigen-presenting cells. J Immunol 2007; 179: 7585-7592.
12. Jacobsen EA, Ochkur SI, Pero RS, Taranova AG, Protheroe CA, Colbert DC, et al., Allergic pulmonary inflammation in mice is dependent on eosinophil-induced recruitment of effector T cells. J Exp Med 2008; 205: 699-710.
13. Walsh ER, Sahu N, Kearley J, Benjamin E, Kang BH, Humbles A, et al., Strain-specific requirement for eosinophils in the recruitment of T cells to the lung during the development of allergic asthma. J Exp Med 2008; 205: 1285-1292.
14. Walsh ER, Thakar J, Stokes K, Huang F, Albert R, August A,. Computational and experimental analysis reveals a requirement for eosinophil-derived IL-13 for the development of allergic airway responses in C57BL/6 mice. J Immunol 2011; 186: 2936-2949.
15. Jacobsen EA, Lee NA, Lee JJ,. Re-defining the unique roles for eosinophils in allergic respiratory inflammation. Clin Exp Allergy 2014; 44: 1119-1136.
16. Lee JJ, Dimina D, Macias MP, Ochkur SI, McGarry MP, O'Neill KR, et al., Defining a link with asthma in mice congenitally deficient in eosinophils. Science 2004; 305: 1773-1776.
17. Finkelman FD, Hogan SP, Hershey GK, Rothenberg ME, Wills-Karp M,. Importance of cytokines in murine allergic airway disease and human asthma. J Immunol 2010; 184: 1663-1674.
18. Van Dyken SJ, Locksley RM,. Interleukin-4- and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease. Annu Rev Immunol 2013; 31: 317-343.
19. Lee NA, McGarry MP, Larson KA, Horton MA, Kristensen AB, Lee JJ,. Expression of IL-5 in thymocytes/T cells leads to the development of a massive eosinophilia, extramedullary eosinophilopoiesis, and unique histopathologies. J Immunol 1997; 158: 1332-1344.
20. McKenzie GJ, Emson CL, Bell SE, Anderson S, Fallon P, Zurawski G, et al., Impaired development of Th2 cells in IL-13-deficient mice. Immunity 1998; 9: 423-432.
21. Shen HH, Ochkur SI, McGarry MP, Crosby JR, Hines EM, Borchers MT, et al., A causative relationship exists between eosinophils and the development of allergic pulmonary pathologies in the mouse. J Immunol 2003; 170: 3296-3305.
22. Stolarski B, Kurowska-Stolarska M, Kewin P, Xu D, Liew FY,. IL-33 exacerbates eosinophil-mediated airway inflammation. J Immunol 2010; 185: 3472-3480.
23. Voehringer D, van Rooijen N, Locksley RM,. Eosinophils develop in distinct stages and are recruited to peripheral sites by alternatively activated macrophages. J Leukoc Biol 2007; 81: 1434-1444.
24. Wen T, Besse JA, Mingler MK, Fulkerson PC, Rothenberg ME,. Eosinophil adoptive transfer system to directly evaluate pulmonary eosinophil trafficking in vivo. Proc Natl Acad Sci USA 2013; 110: 6067-6072.
25. Dyer KD, Moser JM, Czapiga M, Siegel SJ, Percopo CM, Rosenberg HF,. Functionally competent eosinophils differentiated ex vivo in high purity from normal mouse bone marrow. J Immunol 2008; 181: 4004-4009.
26. Lambrecht BN, Hammad H,. Allergens and the airway epithelium response: gateway to allergic sensitization. J Allergy Clin Immunol 2014; 134: 499-507.
27. Kurowska-Stolarska M, Stolarski B, Kewin P, Murphy G, Corrigan CJ, Ying S, et al., IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J Immunol 2009; 183: 6469-6477.
28. Bouffi C, Rochman M, Zust CB, Stucke EM, Kartashov A, Fulkerson PC, et al., IL-33 markedly activates murine eosinophils by an NF-kappaB-dependent mechanism differentially dependent upon an IL-4-driven autoinflammatory loop. J Immunol 2013; 191: 4317-4325.
29. Wills-Karp M,. Interleukin-13 in asthma pathogenesis. Curr Allergy Asthma Rep 2004; 4: 123-131.
30. Johansson MW,. Activation states of blood eosinophils in asthma. Clin Exp Allergy 2014; 44: 482-498.
31. Fukuda T, Dunnette SL, Reed CE, Ackerman SJ, Peters MS, Gleich GJ,. Increased numbers of hypodense eosinophils in the blood of patients with bronchial asthma. Am Rev Res Dis 1985; 132: 981-985.
32. Kim CK, Callaway Z, Kim DW, Kita H,. Eosinophil degranulation is more important than eosinophilia in identifying asthma in chronic cough. J Asthma 2011; 48: 994-1000.
33. Giembycz MA, Lindsay MA,. Pharmacology of the eosinophil. Pharmacol Rev 1999; 51: 213-340.
34. Johansson MW, Annis DS, Mosher DF,. alpha(M)beta(2) integrin-mediated adhesion and motility of IL-5-stimulated eosinophils on periostin. Am J Respir Cell Mol Biol 2013; 48: 503-510.
35. Qiu Y, Nguyen KD, Odegaard JI, Cui X, Tian X, Locksley RM, et al., Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat. Cell 2014; 157: 1292-1308.
36. Heredia JE, Mukundan L, Chen FM, Mueller AA, Deo RC, Locksley RM, et al., Type 2 innate signals stimulate fibro/adipogenic progenitors to facilitate muscle regeneration. Cell 2013; 153: 376-388.
37. Goh YP, Henderson NC, Heredia JE, Red Eagle A, Odegaard JI, Lehwald N, et al., Eosinophils secrete IL-4 to facilitate liver regeneration. Proc Natl Acad Sci USA 2013; 110: 9914-9919.
38. Fulkerson PC, Fischetti CA, McBride ML, Hassman LM, Hogan SP, Rothenberg ME,. A central regulatory role for eosinophils and the eotaxin/CCR3 axis in chronic experimental allergic airway inflammation. Proc Natl Acad Sci USA 2006; 103: 16418-16423.
39. Mattes J, Yang M, Mahalingam S, Kuehr J, Webb DC, Simson L, et al., Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma. J Exp Med 2002; 195: 1433-1444.
40. Lloyd CM, Delaney T, Nguyen T, Tian J, Martinez AC, Coyle AJ, et al., CC chemokine receptor (CCR)3/Eotaxin is followed by CCR4/Monocyte- derived chemokine in mediating pulmonary T helper lymphocyte type 2 recruitment after serial antigen challenge in vivo. J Exp Med 2000; 191: 265-274.
41. Ariel A, Serhan CN,. New lives given by cell death: macrophage differentiation following their encounter with apoptotic leukocytes during the resolution of inflammation. Front Immunol 2012; 3: 4.
42. Wu D, Molofsky AB, Liang HE, Ricardo-Gonzalez RR, Jouihan HA, Bando JK, et al., Eosinophils Sustain Adipose Alternatively Activated Macrophages Associated with Glucose Homeostasis. Science 2011; 332: 243-247.
43. Berry MA, Parker D, Neale N, Woodman L, Morgan A, Monk P, et al., Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis. J Allergy Clin Immunol 2004; 114: 1106-1109.
44. Schmid-Grendelmeier P, Altznauer F, Fischer B, Bizer C, Straumann A, Menz G, et al., Eosinophils express functional IL-13 in eosinophilic inflammatory diseases. J Immunol 2002; 169: 1021-1027.
45. Licona-Limon P, Kim LK, Palm NW, Flavell RA,. TH2, allergy and group 2 innate lymphoid cells. Nat Immunol 2013; 14: 536-542.